Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,225.00
-45.70 (-3.60%)
Oct 23, 2026, 3:29 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 128.15 billion as of October 22, 2026. It is the 8,232nd most valuable company in the world and the 494th biggest in India. Its market cap has decreased by 19.53% in one year.
Market Cap
128.15B
Enterprise Value
123.84B
Revenue
11.08B
Global Rank
Country Rank
#494 India
PE Ratio
46.69
ChartMarket Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 128.15B, an increase of 29.93%. That is a compound annual growth rate of 8.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 128.15B | -8.96% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 553.62B |
| Anthem Biosciences | 455.34B |
| OneSource Specialty Pharma | 156.71B |
| Blue Jet Healthcare | 96.05B |
| Supriya Lifescience | 70.28B |
| Zota Health Care | 47.10B |
| Dishman Carbogen Amcis | 22.86B |
| Panacea Biotec | 21.38B |